| Georgette Nartey, RN | |
|
3 Revere Way, Sicklerville, NJ 08081-9686 | |
| (856) 308-1788 | |
| Not Available |
| Full Name | Georgette Nartey |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Psychiatric/mental Health |
| Location | 3 Revere Way, Sicklerville, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760253314 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP0808X | Registered Nurse - Psychiatric/mental Health | 26NR25376700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Georgette Nartey, RN 3 Revere Way, Sicklerville, NJ 08081-9686 Ph: (856) 308-1788 | Georgette Nartey, RN 3 Revere Way, Sicklerville, NJ 08081-9686 Ph: (856) 308-1788 |
News Archive
Visual distortions and hallucinations related to an elevated risk of psychosis are linked to self-destructive thought processes among adolescents with psychological symptoms, according to a recent Finnish study. Early indications of the risk of psychosis can usually be detected long before the onset of a full-blown disorder.
Prestige Brands Holdings, Inc. today announced the signing of a purchase agreement for the acquisition of Hydralyte in Australia and New Zealand from The Hydration Pharmaceuticals Trust of Victoria, Australia. The acquisition is expected to close, subject to customary closing conditions, during the first quarter of fiscal 2015, which began on April 1, 2014.
"The world is facing two immediate health crises concerning drugs and vaccines: affordable and reliable access to life-sparing medicines and the safety and reliability of those medicines," Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), writes in the council's Policy Innovation Memorandum No. 21, titled, "Ensuring the Safety and Integrity of the World's Drug, Vaccine, and Medicines Supply."
Caraco Pharmaceutical Laboratories, Ltd. has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended release tablets, 100 mg, 150 mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline's Wellbutrin SR® Extended Release tablets.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the first quarter, ended March 31, 2011.
› Verified 8 days ago
Kathryn Calka, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2295 Garwood Rd, Sicklerville, NJ 08081 Phone: 856-784-7441 Fax: 856-784-7338 | |
Natalie Williams Pierson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5 Britt Lea Dr, Sicklerville, NJ 08081 Phone: 609-352-0402 | |
Patricia Ezike, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3 Meade Ct, Sicklerville, NJ 08081 Phone: 718-671-2100 | |
Lisa Hill, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 20 Parliament Rd, Sicklerville, NJ 08081 Phone: 856-404-9703 | |
Aderoju Arasanyin, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7 Hawthorne Rd, Sicklerville, NJ 08081 Phone: 609-456-7593 | |
Bernine Raymond, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 York Ter, Sicklerville, NJ 08081 Phone: 267-774-1853 | |
Mae Johnson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 18 Bridle Path Ct, Sicklerville, NJ 08081 Phone: 800-950-6066 |